藏药独一味滴丸治疗阻生齿拔除术后并发症疗效观察

目的:观察独一味滴丸治疗阻生齿拔除术后并发症的临床疗效。方法:将62例患者随机分为治疗组、对照组各31例。2组均在拔牙术后进行创面常规处理。治疗组术后口服独一味滴丸,疗程3～5天;对照组口服甲硝唑,疗程5～7天。在服药3天后依据拔牙创面有无疼痛、出血和创面感染情况评价疗效。结果:总有效率治疗组为93.55%,对照组为77.42%,2组相比差异显著。结论:独一味滴丸治疗阻生齿拔除术后并发症疗效显著。     

中西医结合治疗急性心肌梗死的临床疗效观察

目的:探讨中西医结合治疗急性心肌梗死(AMI)的临床疗效。方法:选取湛江中心人民医院2017年1月至2018年12月收治的68例AMI患者。随机分为观察组和对照组,各34例。对照组患者行皮下注射低分子肝素钙治疗,观察组患者在对照组的基础上联合芪参益气滴丸治疗。观察比较两组患者心功能指标、血肌酐、后端脑钠肽前体。结果:治疗后,观察组患者的左室射血分数(LVEF)、左室舒张末期容积(LVEDV)、收缩末期容积(LVESV)均显著优于对照组,差异具有统计学意义(P<0.05);两组患者的血肌酐治疗前后比较,差异无统计学意义(P>0.05)。治疗后,观察组的前端脑钠肽前体低于对照组,差异具有统计学意义(P<0.05)。结论:中西医结合治疗AMI能显著改善患者心功能水平,降低后端脑钠肽前体,整体疗效非常显著,具有临床价值。     

高效液相色谱法测定舒筋活血丸中芍药苷的含量

目的：建立舒筋活血丸中芍药苷的含量测定的HpLc方法。方法：KromasilC18柱（150mm&#215;4．6mm,5μm），以乙腈-水（13：87）为流动相，流速1．0ml&#183;min^-1,检测波长230nm。结果：芍药苷在19～77μg&#183;ml^-1范围内与其峰面积呈良好的线性关系（r=0．9996），平均回收率为99．3％RSD=0．7％（n=5）。结论：方法操作简便、准确、重复性好，可用于舒筋活血丸的质量控制。     

益心泰丸抗心肌梗死后大鼠心室重构作用及机理研究

目的:探讨炎性细胞因子系统对心肌梗死后心室重构的影响及益心泰丸对心室重构干预作用。方法:制备心肌梗死大鼠模型。随机分成模型组、益心泰组开博通组、复方丹参滴丸组和假手术组。除模型组和假手术组以蒸馏水等量灌胃,其余各组分别给予相应药物灌胃,用药4周后分别检测心室重构指标及血浆中TNF-α、IL-6含量。结果:与假手术组比较,模型组心脏重量、心脏指数增加(P<0.01);与模型组比较,益心泰组、复方丹参滴丸组和开博通组心脏重量、心脏指数降低(P<0.01)。与假手术组比较,模型组血浆中TNF-α、IL-6含量明显升高(P<0.01),与模型组比较,益心泰组、复方丹参滴丸组和开博通组TNF-α、IL-6含量均有下降(P<0.01)。而益心泰组、复方丹参滴丸组和开博通组心脏指数、TNF-α、IL-6差异无统计学意义(P>0.05)。结论:益心泰丸可能通过调节炎性细胞因子水平,在一定程度上干预了心肌梗死后心室重构。     

阿司匹林联合丹参治疗短暂性脑缺血发作的效果分析

目的：探讨阿司匹林联合丹参在短暂性脑缺血发作治疗中的效果,并将其进行比较分析。方法：选取2007年9月-2009年2月于本院治疗的39例短暂性脑缺血发作患者为研究对象,将其随机分为阿司匹林联合丹参组（A组）13例和阿司匹林组（B组）13例、丹参组（C组）13例,A组采用阿司匹林联合丹参进行治疗,B组采用阿司匹林进行治疗,C组则采用丹参进行治疗,后将三组患者治疗前后的纤维蛋白原的检测结果及治疗效果进行比较。结果：经比较分析,A组与B、C组比较．A组纤维蛋白原明显低于B、C组,且效果方面也优于B、C组,P〈0．05。结论：阿司匹林联合丹参在短暂性脑缺血发作治疗中的效果显著,值得进一步研究探讨。     

What is the seminal exposition among women requiring emergency contraception? A prospective,observational comparative study

OBJECTIVES: The aim of this study is to determine the number of sperm present in the vagina of women presenting for EC after unprotected intercourse or a condom accident. STUDY DESIGN: A total of 69 women requesting EC were included in a prospective, observational and comparative study. The absence or presence and number of spermatozoa present were examined under light microscopy in endocervical and vaginal smears. An ethinylestradiol-levonorgestrel combination (100 mcg/500 mg for two doses, 12 h apart) was then prescribed. Twenty couples were taken as controls. RESULTS: In 25 (36.2%) of the 69 women, spermatozoa were not observed. In the women in whom sperm could be identified, there were no significant differences in the mean (range) sperm count in relation to the reason for requesting EC, i.e., 11.0 (0.03-149.8) for condom slippage or breakage, and 8.1 (3.9-55) for unprotected intercourse. In the group of controls the median (range) number of spermatozoa (32.5 (2.5-304) was significantly higher (p=0.04) than the observed in the study group. CONCLUSIONS: In one-third of the women presenting for EC, no sperm were identified in the vagina. When sperm were present, the number was much lower than that after intercourse among women wishing to conceive. The risk of an unwanted pregnancy is probably, therefore, lower for women who present for EC compared with that for women who truly have unprotected intercourse.     

Anti-Müllerian hormone levels during hormonal contraception in women with polycystic ovary syndrome

OBJECTIVE: The use of oral contraceptive (OC) pills alters the characteristic features of polycystic ovary syndrome (PCOS) complicating the diagnosis of this disease. Anti-Müllerian hormone (AMH) levels are high in PCOS patients and are stable throughout the menstrual cycle in healthy subjects. This study examined the influence of hormonal suppression with OC therapy on the serum AMH levels in women with PCOS and with normal menstrual cycles. STUDY DESIGN: Thirty women with PCOS and 15 women with normal menstrual cycles were enrolled in this prospective study. Serum was collected from the subjects during the early follicular phase of the menstrual cycle and after the sixth cycle of oral contraceptive therapy, and stored frozen until assayed. The effect of OC therapy on the serum AMH, estradiol (E(2)), luteinizing hormone (LH), follicle-stimulating hormone (FSH), free testosterone, total testosterone, and dehydroepiandrosterone sulfate (DHEA-S) levels was studied. In addition, ovarian volume and follicle count were assessed. RESULTS: The serum AMH levels in PCOS patients were significantly higher than in healthy women at baseline (+/-S.D.; 5.49+/-2.26 and 1.93+/-0.51 ng/ml, respectively; p=0.001). After six cycles of OC therapy, no significant changes in the AMH levels were observed in either the PCOS patients or normally cycling women. Ultrasound showed significant reductions in ovarian volume and follicle number and size at 6 months in both groups. CONCLUSION: Although significant reductions were observed in ovarian volume and follicle number, 6 months of contraceptive therapy did not change the serum AMH concentration in either group. AMH may be considered a new marker in PCOS patients who are already on contraceptive treatment.     

康腹止泻片微生物限度检查法验证

目的建立康腹止泻片微生物限度检查法。方法采用培养基稀释法。结果该法能有效消除康腹止泻片在检验条件下对细菌、真菌及酵母菌的抑制作用;控制菌可用常规法检查。结论该法简单、快捷,可用于康腹止泻片的微生物限度检查,有效控制其质量。     

薄层扫描法测定牛黄降压丸及胆南星中猪去氧胆酸的含量

用双波长薄层扫描法测定牛黄降压丸及胆南星中猪去氧胆酸的含量.薄层色谱条件:硅胶G板,氯仿-乙醚-冰醋酸(2:2:1)展开,10%磷钼酸乙醇溶液显色,λ_S=700nm,λ_R=450nm.平均回收率:牛黄降压丸为99.14%,RDS=3.0%,n=5;胆南星为97.52%,RSD=2.9%,n=5.     

揿针埋针联合红花清肝十三味丸治疗早期麦粒肿患者的临床疗效

目的 探索揿针埋针联合红花清肝十三味丸治疗早期麦粒肿患者的临床疗效.方法 选取2017年7月至2019年6月本院收治的126例早期麦粒肿患者作为研究对象,采用区组随机化法分为参照组和实验组,各63例.参照组接受常规抗感染治疗,实验组在参照组基础上并行揿针埋针联合红花清肝十三味丸治疗,比较两组治疗前后主观症状积分、首发非...